Almost three years into his tenure…
Almost three years into his tenure as Lundbeck’s CEO, Charl [...]
Almost three years into his tenure as Lundbeck’s CEO, Charl [...]
Regeneron’s “Science Illuminated” podcast series transforms scientific topics into a [...]
A scientific and civilizational horror story.
Roche will invest $750 million to double the size of [...]
Less than a year after the FDA turned down the [...]
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. [...]
China’s investigator-initiated trials, once praised for their speediness, have been [...]
Aurinia Pharmaceuticals has struck a patent infringement settlement with Teva [...]
B. Braun Medical—a maker of IV solutions for hospitals, among [...]
Moderna and Merck say the experimental vaccine prevented the return [...]